All type 2 diabetes articles
-
NewsAntibiotics can affect the gut microbiome for several years
Researchers have found strong links between a person’s history of antibiotic use and the composition of their gut microbiome, including the diversity of bacterial species.
-
NewsPersonalized predictions of probiotic and prebiotic therapy success by computer models
A new study demonstrated that computer models of gut metabolism can predict which probiotics will successfully establish themselves in a person’s gut and how different prebiotics affect production of health-promoting short-chain fatty acids.
-
NewsNew algorithm enhances microbiome biomarker discovery by integrating biological relationships
Researchers have developed a novel algorithm, Microbiome Elastic Feature Extraction (MEFE), that significantly improves the identification of microbiome biomarkers by incorporating phylogenetic, taxonomic, and functional relationships among microbes.
-
NewsResearchers urge focus on child obesity and gut health to reduce risk of diabetes
Researchers are calling for more study of obesity, gut bacteria and metabolic conditions that arise in childhood and adolescence, with an eye to curbing the global rise of type 2 diabetes.
-
NewsProbiotics combined with antidiabetic drugs overcome the ‘drug black hole’
A new study addressing the ’microbial drug black hole’ proposes a new microbe–drug synergistic therapeutic strategy and advances the development of precision nutrition-based interventions for type 2 diabetes mellitus.
-
NewsExperts propose fibre as first new essential nutrient in 50 years - as gut microbiome research gathers pace
Nutrition experts are calling for dietary fibre to be officially recognised internationally as an essential nutrient - the first ‘new’ essential nutrient in more than 50 years. They point out that the gut microbiome exists almost exclusively on the dietary fibre we eat.
-
NewsMajor breakthrough against diabetes thanks to a microbial molecule that disarms inflammation
Researchers have uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine. TMA, produced by gut bacteria from dietary choline can block a key immune pathway and improve blood sugar control.
-
NewsMetabolites produced in the intestine play a central role in controlling obesity and diabetes
A study has identified a group of metabolites that travel from the intestine to the liver and then to the heart, where they are pumped throughout the body. These metabolites play an important role in controlling metabolic pathways in the liver and insulin sensitivity.
-
NewsType 2 diabetes may double risk of sepsis, large community-based study suggests
Living with type 2 diabetes (T2D) may double the risk of developing sepsis—with those aged younger than 60 years and men particularly susceptible, according to a long-term community-based study in Australia.
-
NewsNighttime pistachio snacking may reshape gut microbiome in prediabetic adults
A new study has determined that nighttime pistachio consumption affects gut bacteria in adults with prediabetes. The potential therapeutic implications of the findings may prove significant for people who are working to improve their metabolic health.
-
NewsNo more copy-pasting: DNA base editing for better Lactobacillus strains
Scientists were able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled them to create a strain that doesn’t produce diabetes-aggravating chemicals.
-
NewsWhat microbes tell us about Nonalcoholic Fatty Liver Disease
Using medical data from more than 1,200 people, specific microbiome signatures have been identified that allow precise prediction of Nonalcoholic Fatty Liver Disease (NAFLD).
-
News‘Transient’ gut bacteria may affect health and guide diet choices
‘Transient’ populations of gut bacteria may contribute to the development of chronic liver disease and diabetes, but a personalised diet plan could lessen the risk, new research suggests.
-
NewsStudy links gut microbiome changes to increased risk of type 2 diabetes
Researchers have found that specific species and strains of bacteria are linked to changes in the functioning of the gut microbiome and a person’s risk of type 2 diabetes.
-
NewsMetformin and AGIs show potential for improved outcomes in COVID-19 patients with type 2 diabetes
A new study has found a significant association between metformin and AGI use and reduced all-cause mortality in COVID-19 patients with Type 2 diabetes. Conversely, insulin use was linked to an increased risk of death.
-
NewsNew approach to measuring ‘healthy microbiomes’ in nature and the gut
Focusing on four common diseases – diabetes, heart disease, depression and bowel cancer – new research provides insights into the importance of a healthy microbiome balance in the human gut and in the environment.
-
NewsCelebrity weight-loss drug helps people with HIV fight fatty liver, study shows
Scientists have found that a medication used to treat diabetes and obesity – and touted on social media for weight loss – can be a powerful weapon against a type of fatty liver disease in people with HIV.
-
NewsGut microbiota acts like an auxiliary liver
Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study.
-
NewsWomen with high-risk HPV and metabolic syndrome have almost three times risk for mortality
Women with both metabolic syndrome and high-risk strains of human papillomavirus (HPV) are at a 2.6 times higher risk for mortality than women without either condition.
-
NewsMice study suggests metabolic diseases may be driven by gut microbiome, loss of ovarian hormones
The gut microbiome interacts with the loss of female sex hormones to exacerbate metabolic disease, including weight gain, fat in the liver and the expression of genes linked with inflammation, researchers found in a new rodent study.